Merck Shares Move To Session Lows, Up 0.4% For Session, As Traders Circulating FDA.gov Alert 'FDA Alerts Healthcare Professionals and Oncology Clinical Investigators about Two Clinical Trials on Hold Evaluating KEYTRUDA® in Patients w/ MM'
Paul Quintaro